Kapil brings in more than two decades of healthcare experience and joins the team from his most recent stint as Vice President and Head of Global/US Market Access Pricing and HEOR at HUTCHMED (A company operating in Rare Disease/Oncology NMEs).

Prior to that role he led the World Wide Commercial teams for SCCHN and GBM tumors at Bristol Myers Squibb (BMS). After joining BMS in 2009 he held increasing level of responsibilities across geographies and functions beginning in India as the Marketing/Alliance lead for the CV and Metabolics Franchise, which he helped build out. Kapil held multiple other roles within the Access organization at BMS including the team lead for Value and Population Health Marketing (within Strategic Payer Marketing) in the US Value Access and Payment Organization. Kapil was instrumental in working with Real World Evidence generated by the HEOR teams and building FDAMA 114 capability for delivering promotional tools across US commercial portfolio to access customers. In his role prior to that, Kapil was the Pricing and Contracting lead for the US Virology portfolio where he drove the alignment of Medical, HEOR and Access strategy to drive value based pricing discussions with access customers, especially for HCV.”